Astellas Pharma joined PPMD for a webinar on May 19, 2021 to provide an update on the company’s ASP0367 development program. Research & Clinical Trial Webinars, Webinars Posted on May 21, 2021 FacebookTwitterLinkedinPin ItWhatsApp You may also like 31:23 Advocating for Access: Insurance 101 Posted on September 29, 2023 Care Webinars, Webinars 29:12 Advocating for Access: Navigating Approved Therapies in Duchenne Posted on August 25, 2023 Care Webinars, Webinars 1:11:00 Webinar: ELEVIDYS Approval: What this means for you and your family Posted on July 14, 2023 Care Webinars, Webinars 46:01:00 Webinar: ENVISION Study Update with Sarepta Therapeutics Posted on June 16, 2023 Research & Clinical Trial Webinars, Webinars 37:54 Community Town Hall: SRP-9001 Advisory Committee Update (May 2023) Posted on May 19, 2023 Research & Clinical Trial Webinars, Webinars 55:52 Webinar: Edgewise — A Novel Approach Designed to Protect Muscle in Becker (May 2023) Posted on May 11, 2023 Research & Clinical Trial Webinars, Webinars 48:49 Webinar: Dyne Therapeutics — Advancing FORCE in the Pursuit of Therapies (April 2023) Posted on April 20, 2023 Research & Clinical Trial Webinars, Webinars 1:01:16 Connect With the Experts: Bone Health in Duchenne (April 2023) Posted on April 15, 2023 Care Webinars, Webinars «12345…24»Page 3 of 24
by: Parent Project Muscular Dystrophy
